explore -WSS

explore

author：comprehensive 2025-10-01 21:37:13 - browse：7

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： How generative AI is inspiring dreams of a health data revolution

WSS

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Weighted lottery helped low

Following judge's order, DOJ releases slightly less

NIH nominee Bertagnolli will get October confirmation hearing

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

NIH nominee Bertagnolli will get October confirmation hearing

knowledge

explore

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

The high cost of giving birth even with insurance

Adele warns fans about throwing things at performers onstage

Hepatitis C has a cure — but many Americans still lack access to it

Covid hospitalizations on the rise, Humana says

Hollywood unions extend contract negotiations for actors

China dismisses criticism of top diplomat's comments appearing to push for race

Psychedelics group wrestles with new pharma identity

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

knowledge

What drug price negotiations mean for Medicare Part D

Pentagon will tighten controls on classified information after Discord leak

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Advances in CAR

AstraZeneca chief proposes a novel edit to the drug pricing bill

What American doctors can learn from their Israeli counterparts

hotspot

focus

focus

focus